MSFT 409.6999 -1.5286% AAPL 222.71 -1.8034% NVDA 128.3057 2.7103% GOOGL 163.14 -2.3465% GOOG 164.6592 -2.3142% AMZN 180.47 -3.2384% META 585.16 -1.8089% AVGO 175.79 -0.4812% TSLA 241.6955 -3.3527% TSM 183.57 1.3303% LLY 899.35 1.374% V 273.29 -1.6695% JPM 209.74 -0.7007% UNH 584.575 -1.1206% NVO 117.48 2.05% WMT 79.45 -1.8409% LVMUY 148.82 1.4451% XOM 125.47 0.5127% LVMHF 745.0 1.5609% MA 491.24 -1.298%
Last update at 2024-10-07T18:50:00Z
Clorox Stock Rises 22% in Three Months: Is it a Buy or Time to Hold?
Fri 04 Oct 24, 03:28 PMWhy Clorox (CLX) is a Top Momentum Stock for the Long-Term
Thu 03 Oct 24, 01:50 PMReflecting On Household Products Stocks’ Q2 Earnings: Central Garden & Pet (NASDAQ:CENT)
Wed 02 Oct 24, 09:34 AMLamb Weston Q1 Earnings Coming Up: Here's What You Should Know
Fri 27 Sep 24, 03:46 PMUNFI Gears Up for Q4 Earnings Release: Things to Keep in Mind
Thu 26 Sep 24, 03:32 PMMcCormick Gears Up for Q3 Earnings Release: Things to Keep in Mind
Wed 25 Sep 24, 03:43 PMBoasting A 59% Return On Equity, Is The Clorox Company (NYSE:CLX) A Top Quality Stock?
Mon 23 Sep 24, 01:56 PMIs The Clorox Company (CLX) The Best Household and Personal Care Stocks to Buy Now?
Mon 23 Sep 24, 08:47 AM3 Dividend Stocks to Buy Now That Have Raised Their Payouts for at Least 20 Consecutive Years
Thu 19 Sep 24, 11:30 AM| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Income before tax | 238.00M | 607.00M | 900.00M | 1185.00M | 1024.00M |
| Minority interest | -12.00000M | -9.00000M | 181.00M | 181.00M | 181.00M |
| Net income | 149.00M | 462.00M | 710.00M | 939.00M | 820.00M |
| Selling general administrative | 1183.00M | 954.00M | 1004.00M | 969.00M | 856.00M |
| Selling and marketing expenses | 734.00M | 709.00M | 790.00M | 675.00M | 612.00M |
| Gross profit | 2908.00M | 2545.00M | 3199.00M | 3063.00M | 2728.00M |
| Reconciled depreciation | 236.00M | 224.00M | 211.00M | 180.00M | 180.00M |
| Ebit | 1224.00M | 489.00M | 1117.00M | 1104.00M | 941.00M |
| Ebitda | 773.00M | 713.00M | 1328.00M | 1284.00M | 1121.00M |
| Depreciation and amortization | -451.00000M | 224.00M | 211.00M | 180.00M | 180.00M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 1224.00M | 489.00M | 1117.00M | 1104.00M | 941.00M |
| Other operating expenses | 6536.00M | 6357.00M | 6085.00M | 5447.00M | 5090.00M |
| Interest expense | 90.00M | 106.00M | 99.00M | 99.00M | 97.00M |
| Tax provision | 77.00M | 136.00M | 181.00M | 246.00M | 204.00M |
| Interest income | 16.00M | 5.00M | 5.00M | 2.00M | 3.00M |
| Net interest income | -90.00000M | -106.00000M | -99.00000M | -97.00000M | -94.00000M |
| Extraordinary items | - | - | - | - | 0.00000M |
| Non recurring | 445.00M | - | 329.00M | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 77.00M | 136.00M | 181.00M | 246.00M | 204.00M |
| Total revenue | 7389.00M | 7107.00M | 7341.00M | 6721.00M | 6214.00M |
| Total operating expenses | 2055.00M | 1795.00M | 1943.00M | 1789.00M | 1604.00M |
| Cost of revenue | 4481.00M | 4562.00M | 4142.00M | 3658.00M | 3486.00M |
| Total other income expense net | -525.00000M | 118.00M | -217.00000M | 81.00M | 83.00M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 161.00M | 471.00M | 719.00M | 939.00M | 820.00M |
| Net income applicable to common shares | 149.00M | 462.00M | 710.00M | 939.00M | 820.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Total assets | 5945.00M | 6158.00M | 6334.00M | 6213.00M | 5116.00M |
| Intangible assets | 712.00M | 884.00M | 918.00M | 894.00M | 912.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 77.00M | 106.00M | 154.00M | 47.00M | 51.00M |
| Total liab | 5557.00M | 5429.00M | 5742.00M | 5305.00M | 4557.00M |
| Total stockholder equity | 220.00M | 556.00M | 411.00M | 908.00M | 559.00M |
| Deferred long term liab | 28.00M | 66.00M | 67.00M | 62.00M | 50.00M |
| Other current liab | 121.00M | 509.00M | 745.00M | 25.00M | 9.00M |
| Common stock | 131.00M | 131.00M | 131.00M | 159.00M | 159.00M |
| Capital stock | 131.00M | 131.00M | 131.00M | 159.00M | 159.00M |
| Retained earnings | 583.00M | 1048.00M | 1036.00M | 3567.00M | 3150.00M |
| Other liab | 832.00M | 857.00M | 901.00M | 817.00M | 830.00M |
| Good will | 1252.00M | 1558.00M | 1575.00M | 1577.00M | 1591.00M |
| Other assets | 462.00M | 315.00M | 378.00M | 1451.00M | 217.00M |
| Cash | 367.00M | 183.00M | 319.00M | 871.00M | 111.00M |
| Cash and equivalents | 367.00M | 183.00M | 319.00M | 871.00M | 111.00M |
| Total current liabilities | 1917.00M | 1784.00M | 2056.00M | 1418.00M | 1440.00M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 2557.00M | 2920.00M | 2847.00M | 2251.00M | 2572.00M |
| Short term debt | 137.00M | 315.00M | 381.00M | 64.00M | 396.00M |
| Short long term debt | 50.00M | 237.00M | 300.00M | - | 396.00M |
| Short long term debt total | 2924.00M | 3103.00M | 3166.00M | 3122.00M | 2683.00M |
| Other stockholder equity | -1.00000M | -144.00000M | -210.00000M | -2178.00000M | -2148.00000M |
| Property plant equipment | 1691.00M | 1676.00M | 1634.00M | 1408.00M | 1034.00M |
| Total current assets | 1828.00M | 1725.00M | 1829.00M | 2020.00M | 1305.00M |
| Long term investments | - | - | - | - | 57.00M |
| Net tangible assets | -1744.00000M | -1886.00000M | -2082.00000M | -1563.00000M | 559.00M |
| Short term investments | - | - | - | - | - |
| Net receivables | 688.00M | 681.00M | 604.00M | 648.00M | 631.00M |
| Long term debt | 2477.00M | 2474.00M | 2484.00M | 2780.00M | 2287.00M |
| Inventory | 696.00M | 755.00M | 752.00M | 454.00M | 512.00M |
| Accounts payable | 1659.00M | 960.00M | 1675.00M | 1329.00M | 1035.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | 168.00M | 173.00M | 181.00M | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -493.00000M | -479.00000M | -546.00000M | -640.00000M | -602.00000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | 131.00M | 131.00M | 131.00M | 159.00M | 159.00M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | 583.00M | 1048.00M | 1036.00M | 3567.00M | 3150.00M |
| Treasury stock | - | - | -1396.00000M | -3315.00000M | -3194.00000M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 462.00M | 315.00M | 378.00M | 328.00M | 274.00M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 4117.00M | 4433.00M | 4505.00M | 4193.00M | 3811.00M |
| Capital lease obligations | 397.00M | 392.00M | 382.00M | 342.00M | - |
| Long term debt total | 2477.00M | 2474.00M | 2484.00M | 2792.00M | 2287.00M |
| Breakdown | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 |
| Investments | -223.00000M | -229.00000M | -452.00000M | -252.00000M | -196.00000M |
| Change to liabilities | 309.00M | -12.00000M | 311.00M | 305.00M | 43.00M |
| Total cashflows from investing activities | -223.00000M | -229.00000M | -452.00000M | -252.00000M | -196.00000M |
| Net borrowings | -188.00000M | -83.00000M | -83.00000M | 96.00M | 189.00M |
| Total cash from financing activities | -753.00000M | -689.00000M | -1391.00000M | -523.00000M | -815.00000M |
| Change to operating activities | - | 15.00M | -32.00000M | 21.00M | -6.00000M |
| Net income | 161.00M | 471.00M | 719.00M | 939.00M | 820.00M |
| Change in cash | 182.00M | -138.00000M | -555.00000M | 766.00M | -21.00000M |
| Begin period cash flow | 186.00M | 324.00M | 879.00M | 113.00M | 134.00M |
| End period cash flow | 368.00M | 186.00M | 324.00M | 879.00M | 113.00M |
| Total cash from operating activities | 1158.00M | 786.00M | 1276.00M | 1546.00M | 992.00M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 236.00M | 224.00M | 211.00M | 180.00M | 180.00M |
| Other cashflows from investing activities | 5.00M | 22.00M | -36.00000M | 2.00M | 10.00M |
| Dividends paid | 583.00M | 571.00M | 558.00M | 533.00M | 490.00M |
| Change to inventory | 58.00M | -18.00000M | -282.00000M | 50.00M | -7.00000M |
| Change to account receivables | -14.00000M | -84.00000M | 82.00M | -27.00000M | -38.00000M |
| Sale purchase of stock | 33.00M | -25.00000M | -905.00000M | -248.00000M | -661.00000M |
| Other cashflows from financing activities | -170.00000M | 1312.00M | 72.00M | 258.00M | 336.00M |
| Change to netincome | 407.00M | 76.00M | 366.00M | 78.00M | -6.00000M |
| Capital expenditures | 228.00M | 251.00M | 331.00M | 254.00M | 206.00M |
| Change receivables | -13.00000M | -84.00000M | 82.00M | -27.00000M | -32.00000M |
| Cash flows other operating | - | 129.00M | -32.00000M | 21.00M | 814.00M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | 182.00M | -132.00000M | -567.00000M | 771.00M | -19.00000M |
| Change in working capital | 354.00M | -99.00000M | -11.00000M | 349.00M | -2.00000M |
| Stock based compensation | 73.00M | 52.00M | 50.00M | 50.00M | 43.00M |
| Other non cash items | 483.00M | 133.00M | 339.00M | 30.00M | -29.00000M |
| Free cash flow | 930.00M | 535.00M | 945.00M | 1292.00M | 786.00M |
Sector: Consumer Defensive Industry: Household & Personal Products
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CLX The Clorox Company |
-1.59 0.98% | 159.98 | 202.66 | 30.58 | 2.48 | 56.11 | 2.86 | 41.85 |
| PG Procter & Gamble Company |
-1.61 0.95% | 167.27 | 23.58 | 22.62 | 4.07 | 7.24 | 4.40 | 16.08 |
| LRLCF L'Oréal S.A |
-15.96 3.62% | 424.35 | 41.14 | 34.25 | 6.52 | 8.59 | 6.67 | 27.76 |
| LRLCY L’Oreal Co ADR |
-0.61 0.70% | 86.31 | 41.27 | 33.90 | 6.56 | 8.50 | 6.65 | 27.67 |
| UL Unilever PLC ADR |
-0.63 1.00% | 62.21 | 13.41 | 15.48 | 1.95 | 5.63 | 2.38 | 10.29 |
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. It sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The Clorox Company was founded in 1913 and is headquartered in Oakland, California.
1221 Broadway, Oakland, CA, United States, 94612-1888
| Name | Title | Year Born |
|---|---|---|
| Ms. Linda Rendle | CEO & Director | 1978 |
| Mr. Kevin B. Jacobsen | Exec. VP & CFO | 1966 |
| Mr. Eric H. Reynolds | Exec. VP & COO | 1970 |
| Ms. Kirsten M. Marriner | Exec. VP and Chief People & Corp. Affairs Officer | 1973 |
| Ms. Rebecca Dunphey | Group Pres of Care & Connection | 1978 |
| Ms. Laura E. Peck | VP, Chief Accounting Officer & Corp. Controller | 1977 |
| Ms. Chau Banks | Sr. VP and Chief Information & Enterprise Analytics Officer | 1969 |
| Lisah Burhan | VP of Investor Relations | NA |
| Ms. Angela C. Hilt | Exec. VP & Chief Legal Officer | 1972 |
| Mr. Eric Sean Schwartz | Sr. VP & Chief Marketing Officer | 1972 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
US 
AU
UK
CA
NZ
Please wait processing your request...